Difference between revisions of "Al Shahrani M"
From Bioblast
(Created page with "{{Person}}") |
Nirschl Lisa (talk | contribs) |
||
| (10 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{Person}} | {{Person | ||
|lastname=Al Shahrani | |||
|firstname=Mesfer | |||
|institution=The National Hospital for Neurology & Neurosurgery | |||
Neurometabolic Unit | |||
|address=Queen Square | |||
|area code=WC1N 3BG | |||
|city=London | |||
|country=United Kingdom | |||
}} | |||
{{Labelingperson}} | |||
== Participated at == | |||
::::*[[IOC101| IOC101 London UK]] | |||
::::* [[IOC100| IOC100 Schroecken AT]] | |||
Latest revision as of 10:49, 26 April 2018
| Name | Al Shahrani Mesfer, |
|---|---|
| Institution | The National Hospital for Neurology & Neurosurgery
Neurometabolic Unit |
| Address | Queen Square, WC1N 3BG |
| City | London |
| State/Province | |
| Country | United Kingdom |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | UK London Land JM |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Hargreaves 2016 Drug Saf | 2016 | Hargreaves IP, Al Shahrani M, Wainwright L, Heales SJR (2016) Drug-induced mitochondrial toxicity. Drug Saf 39:661–74. https://doi.org/10.1007/s40264-016-0417-x. |
